Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | LGALS3 | P17931 | 5/20 | 0.48 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.46 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.46 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.46 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.46 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | OGA | O60502 | 1/20 | 0.44 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.43 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.43 |
| ▸ | HRAS | P01112 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 2/20 | 0.43 |
| ▸ | SI | P14410 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8566966 | 0.96 | LGALS8 (0.61) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL8566963 | 0.96 | LGALS8 (0.61) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL14747275 | 0.96 | LGALS8 (0.61) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL25084120 | 0.89 | LGALS8 (0.66) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL9520093 | 0.89 | LGALS8 (0.66) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL9847337 | 0.89 | LGALS8 (0.66) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL16099956 | 0.89 | LGALS8 (0.66) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL20658674 | 0.89 | LGALS8 (0.66) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL20671054 | 0.89 | LGALS8 (0.66) | LGALS8SLC6A2LGALS3SSTR1SSTR2 | |
| SCHEMBL7751644 | 0.89 | SLC6A2 (0.58) | LGALS8SLC6A2LGALS3SSTR1SSTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0749423-B1 | PIPERIDINES AND PYRROLIDINES | NOVO NORDISK AS (DK) | 2003-06-18 | — | — | EP | disclosed |
| US-6046214-A | USEFUL IN TREATMENT AND/OR PREVENTION OF DIABETES, AND ESPECIALLY NON-INSULIN DEPENDENT DIABETES (NIDDM OR TYPE 2 DIABETES) INCLUDING OVERNIGHT OR MEAL TREATMENT AND TREATMENT OR PREVENTION OF LONGTERM COMPLICATIONS, SUCH AS RETINOPATHY | NOVO NORDISK A/S (DK) | 2000-04-04 | — | — | US | disclosed |
| EP-0983239-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 2000-03-08 | — | — | EP | disclosed |
| US-5863903-A | ANTIDIABETIC AGENT | NOVO NORDISK A/S (DK) | 1999-01-26 | — | — | US | disclosed |
| US-5844102-A | Glycohydrolase inhibitors, their preparation and use thereof | UNIVERSITY OF MARYLAND BALTIMORE COUNTY (US) | 1998-12-01 | — | — | US | disclosed |
| WO-1998050359-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 1998-11-12 | — | — | WO | disclosed |
| WO-1995024391-A1 | PIPERIDINES AND PYRROLIDINES | NOVO NORDISK A/S (DK) | 1995-09-14 | — | — | WO | disclosed |